Objective: There is a high prevalence of congenital heart defects in patients with Turner's
syndrome. Few studies have reported echocardiographic data in unselected patients …

OBJECTIVE: Genetic syndromes occur in more than 20% of patients with conotruncal heart
defects. We investigated the impact of genetic syndromes on the surgical outcome of …

The prevalence of congenital and acquired heart disease in patients with the Turner
syndrome (TS) is based on historic cohorts who underwent imaging before the advent of …

We sought to evaluate the mortality, risk factors for mortality, and resource utilization
following cardiac interventions in trisomy 13 (T13) and 18 (T18) children. All T13 and T18 …

Objective To compare the incidence and type of heart disease found in association with 45X
karyotype in fetal life with postnatal life and to examine the outcome after fetal diagnosis …

Intensive cardiac management such as pharmacological intervention for ductal patency
(indomethacin and/or mefenamic acid for closure and prostaglandin E1 for maintenance) …

Fetal cardiology includes the assessment of the fetal heart for congenital heart disease
(CHD) and arrhythmias, the management of affected fetuses, including parental counselling …

The preferential association between Turner's syndrome and congenital heart defects (CHD)
have been well known since the first description by Morgagni. There are few studies about …

Congenital heart diseases represent one of the hallmarks of 22q11. 2 deletion syndrome. In
particular, conotruncal heart defects are the most frequent cardiac malformations and are …

There has been substantial controversy regarding treatment of congenital heart defects in
infants with trisomies 13 and 18. Most reports have focused on surgical outcomes versus …